FY2025 EPS Estimates for Prime Medicine Increased by Analyst
Prime Medicine, Inc. (NYSE:PRME – Free Report) – Chardan Capital raised their FY2025 earnings per share (EPS) estimates for Prime Medicine in a research note issued on Tuesday, May 20th. Chardan Capital analyst G. Livshits now expects that the company will earn ($1.25) per share for the year, up from their previous estimate of ($1.39). […]
Prime Medicine, Inc. (NYSE:PRME – Free Report) – Chardan Capital raised their FY2025 earnings per share (EPS) estimates for Prime Medicine in a research note issued on Tuesday, May 20th. Chardan Capital analyst G. Livshits now expects that the company will earn ($1.25) per share for the year, up from their previous estimate of ($1.39). […]
